During the past decade, Medical Oncology and Immunotherapy Unit, University Hospital of Siena conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Oncology and Immunotherapy Unit, University Hospital of Siena" #1 collaborator was "Astex Pharmaceuticals, Inc." with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "MedImmune LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Medical Oncology and Immunotherapy Unit, University Hospital of Siena" are "Malignant Mesothelioma" (2 trials), "Brain Metastases" (1 trials), "Metastatic Melanoma" (1 trials), "Metastatic Pancreatic Cancer" (1 trials) and "Myelofibrosis" (1 trials). Many other conditions were trialed in "Medical Oncology and Immunotherapy Unit, University Hospital of Siena" in a lesser frequency.

Most popular intervention types in "Medical Oncology and Immunotherapy Unit, University Hospital of Siena" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Tremelimumab" (2 trials), "Avelumab Injection" (1 trials), "Cisplatin" (1 trials), "Fotemustine" (1 trials) and "Fotemustine and Ipilimumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medical Oncology and Immunotherapy Unit, University Hospital of Siena" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Medical Oncology and Immunotherapy Unit, University Hospital of Siena". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Medical Oncology and Immunotherapy Unit, University Hospital of Siena, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Medical Oncology and Immunotherapy Unit, University Hospital of Siena, 3 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".